Search results for C-terminal

Anti-KCNK1/TWIK1 antibody - C-terminal, Abcam, AB211299

Anti-KCTD3 antibody [EPR14398] - C-terminal, Abcam, AB184561

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Cyclin D1 antibody - C-terminal, Abcam, AB185241

Anti-CYP1B1 antibody [EPR14972] - C-terminal, Abcam, AB185954

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-FDPS/FPS antibody - C-terminal, Abcam, AB189874

Anti-FGF 23 antibody - C-terminal, Abcam, AB190673

Anti-CD16 antibody [EPR16784] - C-terminal, Abcam, AB198507

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD163 antibody [EPR14643] - C-terminal, Abcam, AB188571

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD16a antibody [SP189] - C-terminal, Abcam, AB227665

Anti-Collagen III antibody - C-terminal, Abcam, AB216430